title: Naegleria meningitis: a rare survival.
abstract: Acute amebic meningoencephalitis caused by free-living amebae naegleria fowleri is extremely rare and uniformly fatal with only seven survivals reported till date. An interesting case of naegleria meningitis diagnosed by wet mount cytology of cerebrospinal fluid (CSF) and treated with amphoterecin B, rifampicin and ornidazole with complete recovery is presented. In cases of suspected pyogenic meningitis, if CSF staining, antigen detection or culture is negative for bacteria, a wet mount cytology of CSF for naegleria is suggested. Early treatment with amphoterecin B and rifampicin may improve survival.
authors.affiliation: Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012, India.
authors.forename: R
authors.initials: R
authors.lastname: Jain
authors.forename: S
authors.initials: S
authors.lastname: Prabhakar
authors.forename: M
authors.initials: M
authors.lastname: Modi
authors.forename: R
authors.initials: R
authors.lastname: Bhatia
authors.forename: R
authors.initials: R
authors.lastname: Sehgal
mesh_terms: D000328:Adult; D000562:Amebiasis / Q000134:cerebrospinal fluid / Q000150:complications* / Q000175:diagnosis; D000563:Amebicides / Q000627:therapeutic use; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008581:Meningitis / Q000469:parasitology*; D016848:Naegleria fowleri; D009950:Ornidazole / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000563:Amebicides; D000981:Antiprotozoal Agents; D009950:Ornidazole; D000666:Amphotericin B; D012293:Rifampin